Increasing the economic efficacy of peripheral blood progenitor cell collections by monitoring peripheral blood CD34+ concentrations

Transfusion

Volumn 50, Issue 3, 2010, Pages 656-662

  Gutensohn, Kai ^a   Magens, Mirko M ^b   Kuehnl, Peter ^b   Zeller, Wolfgang ^b  

^a Aescu Labor Hamburg   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANTIGEN DETECTION; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; COST CONTROL; DRUG COST; DRUG EXPOSURE; DRUG RESPONSE; DRUG USE; FEMALE; HEALTH CARE COST; HUMAN; LEUKAPHERESIS; LEUKOCYTE; MALE; MONEY; PERIPHERAL BLOOD STEM CELL; STEM CELL MOBILIZATION;

ADULT; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 77649197719     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02466.x     Document Type: Article

References (32)

1. Gratwohl A. Bone marrow transplantation activity in Europe 1990. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1991 8 : 197 201.
2. Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1999 24 : 231 45.
3. Kiss J, Rybka W, Winkelstein A, deMagalhaes-Silverman M, Lister J, D'Andrea P, Ball ED. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997 19 : 303 10.
4. Schwella N, Siegert W, Beyer J, Rick O, Zingsem J, Eckstein R, Serke S, Huhn D. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution. Ann Hematol 1995 71 : 227 34.
5. Weaver C, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995 86 : 3961 9.
6. Beyer J, Schwella N, Zingsem J, Strohscheer I, Schwaner I, Oettle H, Serke S, Huhn D, Stieger W. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995 13 : 1328 35.
7. Bender J, To L, William S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992 1 : 329 41.
8. Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C. CD34 counts to predict collection of adequate peripheral blood progenitor cells. Bone Marrow Transplant 1997 20 : 587 91.
9. Fontao-Wendel R, Lazar A, Melges S, Altobeli C, Wendel S. The absolute number of circulating CD34+ cells as the best predictor of peripheral hematopoietic stem cell yield. J Hematother 1999 8 : 255 62.
10. Gutensohn K, Magens M, Kühnl P. Flow cytometry: the standard for monitoring the onset of apheresis and for the evaluation of stem and progenitor cell graft quality. Vox Sang 2000 78 : 131 5.
11. Yu L, Leisenring W, Bensinger W, Holmberg LA, Rowley SD. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 1999 39 : 442 50.
12. Höglund M, Smedmyr B, Simonsson B, Tötterman T, Bengtsson M. Dose-dependent mobilization of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 1996 18 : 19 27.
13. Luider J, Brown C, Selinger S, Quinlan D, Karlsson L, Ruehter D, Stewart D, Klassen J, Russel JA. Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresis. J Hematother 1997 6 : 575 80.
14. Kröger N, Krüger W, Renges H, Zeller W, Rauhoft C, Löliger C, Zander AR. Comparison of progenitor cell collection on day 4 or day 5 after steady-state stimulation with G-CSF alone in breast cancer patients: influence on CD34+ cell yield, subpopulation, and breast cancer cell contamination. J Hematother 2000 9 : 111 7.
15. Sutherland D, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996 5 : 213 26.
16. Gutensohn K, Magens M, Kroeger N, Krueger W, Brockmann MA, Gutensohn J, Kuehnl P. Monitoring the timing of peripheral blood stem cell apheresis: application of the hematopoietic progenitor cell analysis. Infus Ther Transfus Med 2001 28 : 271 6.
17. Magens MM, Brockmann M-A, Kühnl P, Gutensohn K. Monitoring of peripheral blood progenitor cells (PBPC) in patients with non-Hodgkin's lymphoma: flow cytometric analysis in comparison to a non-immunologic approach [abstract 6th Annual ISHAGE Meeting; 2000 June 15-18; San Diego, CA. ISHAGE Annu Meet Program 2000 65 : 34.
18. Passos-Coelho J, Braine H, Davis J, Huelskamp AM, Schepers KG, Ohly K, Clarke B, Wright SK, Noga S, Davidson NE. Predictive factors for peripheral blood progenitor cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995 13 : 705 14.
19. Remes K, Matinlauri I, Grenman S, Itälä M, Kauppila M, Pelliniemi TT, Salminen E, Vanharanta R, Rajamäki A. Daily measurement of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery. J Hematother 1997 6 : 13 9.
20. Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y, Steenssens L, van Camp B, De Waele M. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996 17 : 509 15.
21. Bensinger W, Weaver C, Appelbaum F, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995 85 : 1655 8.
22. de-la-Rubia J, Martinez C, Solano C, Brunet S, Cascón P, Arrieta R, Alegre A, Bargay J, de Arriba F, Cañizo C, López J, Serrano D, Verdeguer A, Torrabadella M, Díaz MA, Insunza A, de la Serna J, Espigado I, Petit J, Martínez M, Benlloch L, Sanz MA for the Spanish Group of Allo-PBT. Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBMT. Bone Marrow Transplant 1999 24 : 723 8.
23. Anderlini P, Körbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, Howe C, Leitman S, Horowitz M, Gluckman E, Rowley S, Przepiorka D, Champlin R. Allogeneic blood stem cell transplantation: considerations for donors. Blood 1997 90 : 903 8.
24. Finkel E. Telomeres: keys to senescence and cancer. Lancet 1998 351 : 1186.
25. Majolino I, Cavallaro A, Bacigalupo A, Rambaldi A, Falda M, Locatelli F, Raimondi R, Pucci G, Mordini N, Barbui T, Locatelli F, Rodeghiero F, Irrera G, Indovina A, Valbonesi M, Bellavita P, Tassi V, Perotti C, Soli M, Bresolin G. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Group (GITMO). Haematologica 1997 82 : 47 52.
26. Wynn R, Cross M, Hatton C, Will AM, Lashford LS, Dexter TM, Testa NG. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 1998 351 : 178 81.
27. Resch K. Filgrastim. In : Scholz H, Schwabe U, editors. Taschenbuch der Arzneibehandlung. Muenchen : Urban und Fischer 2000. p. 520.
28. Areman E, Rhodes K, Meehan K, Sacher R. Costs of autologous peripheral blood stem cell (PBSC) transplantation can be reduced by PB CD34 screening before apheresis [abstract 4198]. Blood 1997 90 : 322b
29. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994 87 : 609 13.
30. Sekhsaria S, Fleisher T, Vowells S, Brown M, Miller J, Gordon I, Blaese RM, Dunbar CE, Leitman S, Malech HL. Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: impaired mobilization in chronic granulomatous disease and adenosine deaminase-deficient severe combined immunodeficiency disease patients. Blood 1996 88 : 1104 12.
31. Stroncek D, Clay M, Herr G, Smith J, Jaszcz WB, Ilstrup S, McCullough J. The kinetics of G-CSF mobilization of CD34+ cells in healthy people. Transf Med 1997 7 : 19 24.
32. Tabilio A, Falzetti F, Giannoni C, Aversa F, Martelli MP, Rossetti M, Caputo P, Chionne F, Gambelunghe C, Martelli MF. Stem cell mobilization in normal donors. J Hematother 1997 6 : 227 34.